GUGLIELMINI, PAMELA FRANCESCA
GUGLIELMINI, PAMELA FRANCESCA
66 - Dipartimento di Oncologia, Biologia e Genetica (attivo dal 01/01/1900 al 01/01/2012)
Chemotherapy (CT) versus tamoxifen (T) versus chemoterapy plus tamoxifen (CTT) in patients with node-positive (N+), estrogen receptor-positive (ER+) breast cancer (bca): Very late results of an Italian multicentric trial
2010-01-01 Boccardo, Francesco; Guglielmini, PAMELA FRANCESCA; Marasco, A.; Rubagotti, Alessandra
Combination of sorafenib and weekly gemcitabine in patients (pts) with metastatic renal cell Cancer (MRCC): A phase II study, preliminary results
2008-01-01 Tomasello, Laura; Sertoli, MARIO ROBERTO; Rubagotti, Alessandra; Guglielmini, PAMELA FRANCESCA; Tacchini, Laura; Bedognetti, Davide; Ricci, Francesco; Sanguineti, S.; Cassata, A.; Boccardo, Francesco
O-4 Ovarian suppression (OS) and tamoxifen (TAM) as an alternative to chemotherapy in early breast cancer. Long-term results of the GROCTA02 trial
2007-01-01 Boccardo, Francesco; Rubagotti, Alessandra; Guglielmini, PAMELA FRANCESCA; Mesiti, D.; Durando, Andrea; Bolognesi, Alessandra; Farris, A.
Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
2012-01-01 Guglielmini, PAMELA FRANCESCA; Rubagotti, Alessandra; Boccardo, Francesco
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial
2021-01-01 Filaci, G.; Fenoglio, D.; Nole, F.; Zanardi, E.; Tomasello, L.; Aglietta, M.; Del Conte, G.; Carles, J.; Morales-Barrera, R.; Guglielmini, P.; Scagliotti, G.; Signori, A.; Parodi, A.; Kalli, F.; Astone, G.; Ferrera, F.; Altosole, T.; Lamperti, G.; Criscuolo, D.; Gianese, F.; Boccardo, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Chemotherapy (CT) versus tamoxifen (T) versus chemoterapy plus tamoxifen (CTT) in patients with node-positive (N+), estrogen receptor-positive (ER+) breast cancer (bca): Very late results of an Italian multicentric trial | 1-gen-2010 | Boccardo, Francesco; Guglielmini, PAMELA FRANCESCA; Marasco, A.; Rubagotti, Alessandra | |
| Combination of sorafenib and weekly gemcitabine in patients (pts) with metastatic renal cell Cancer (MRCC): A phase II study, preliminary results | 1-gen-2008 | Tomasello, Laura; Sertoli, MARIO ROBERTO; Rubagotti, Alessandra; Guglielmini, PAMELA FRANCESCA; Tacchini, Laura; Bedognetti, Davide; Ricci, Francesco; Sanguineti, S.; Cassata, A.; Boccardo, Francesco | |
| O-4 Ovarian suppression (OS) and tamoxifen (TAM) as an alternative to chemotherapy in early breast cancer. Long-term results of the GROCTA02 trial | 1-gen-2007 | Boccardo, Francesco; Rubagotti, Alessandra; Guglielmini, PAMELA FRANCESCA; Mesiti, D.; Durando, Andrea; Bolognesi, Alessandra; Farris, A. | |
| Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. | 1-gen-2012 | Guglielmini, PAMELA FRANCESCA; Rubagotti, Alessandra; Boccardo, Francesco | |
| Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial | 1-gen-2021 | Filaci, G.; Fenoglio, D.; Nole, F.; Zanardi, E.; Tomasello, L.; Aglietta, M.; Del Conte, G.; Carles, J.; Morales-Barrera, R.; Guglielmini, P.; Scagliotti, G.; Signori, A.; Parodi, A.; Kalli, F.; Astone, G.; Ferrera, F.; Altosole, T.; Lamperti, G.; Criscuolo, D.; Gianese, F.; Boccardo, F. |